NuCana (NCNA) Asset Writedowns and Impairment (2021 - 2024)

NuCana's (NCNA) quarterly Asset Writedowns and Impairment came in at -$42355.6 in Q4 2024, up 93.22% year-on-year from -$21921.4 in Q1 2024, and up 93.22% quarter-over-quarter from -$624299.4 in Q4 2023.

NuCana (NCNA) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends

NuCana has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting -$42355.6 for Q4 2024.

  • Asset Writedowns and Impairment for Q4 2024 came in at -$42355.6, up 93.22% year-over-year; the trailing twelve-month figure through Dec 2024 was -$4.8 million (changed N/A YoY), and the FY2024 annual result was -$42183.1, up 93.26% from the prior year.
  • Asset Writedowns and Impairment came in at -$42355.6 for Q4 2024 at NuCana, up from -$624299.4 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of -$42355.6 in Q4 2024 to a low of -$3.8 million in Q4 2021.
  • The 4-year median for Asset Writedowns and Impairment is -$483397.2 (2023), against an average of -$1.2 million.
  • Across the five-year window, Asset Writedowns and Impairment sank 82.28% in 2023 and surged 93.22% in 2024, its largest moves.
  • NuCana's Asset Writedowns and Impairment stood at -$3.8 million in 2021, then surged by 90.95% to -$342495.1 in 2022, then sank by 82.28% to -$624299.4 in 2023, then soared by 93.22% to -$42355.6 in 2024.
  • The last three Asset Writedowns and Impairment figures came in at -$42355.6 (Q4 2024), -$624299.4 (Q4 2023), and -$342495.1 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 NuCana 29.13 Bn 29.13 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -42,355.56
Dec 31, 2024 -42,355.56
Dec 31, 2023 -624,299.40
Dec 31, 2023 -624,299.40
Dec 31, 2022 -342,495.07
Dec 31, 2022 -342,495.07
Dec 31, 2021 -3.79 Mn
Dec 31, 2021 -3.79 Mn